Combination of Oral Tripterygium Glycosides and angiotensin II receptor blockers for treatment of clinical stage diabetic kidney disease: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Combination of Oral Tripterygium Glycosides and angiotensin II receptor blockers for treatment of clinical stage diabetic kidney disease: A systematic review and meta-analysis of randomized controlled trials

Published:2020-10 Issue: Volume:39 Page:101197
ISSN:1876-3820
Container-title:European Journal of Integrative Medicine
language:en
Short-container-title:European Journal of Integrative Medicine

Author:

Wang Ying,Han Mei,Pedigo Christopher E.,Zhao Nanqi,Liu Jian-Ping

Funder

key program of the National Natural Science Foundation of China

Ying Wang was funded by China Scholarship Council

Publisher

Elsevier BV

Subject

Complementary and alternative medicine

Reference69 articles.

1. Erratum. Sodium-glucose cotransporter 2 inhibition and diabetic kidney disease;Alicic;Diabetes,2019

2. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies;Warren;Expert Opin. Ther. Targets,2019

3. Increasing ESKD in diabetes in the land down under: what can be done, we must wonder;Rossing;Am. J. Kidney Dis.,2019

4. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017;Collaborators GBDCoD;Lancet,2018

5. Canagliflozin and renal events in diabetes with established nephropathy clinical evaluation and study of diabetic nephropathy with atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?;Fernandez-Fernandez;Clin. Kidney J.,2019

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Chinese patent medicines for diabetic kidney disease: An overview of systematic reviews;European Journal of Integrative Medicine;2023-08

2. Efficacy and safety of Tripterygium wilfordii polyglycosides for diabetic kidney disease: an overview of systematic reviews and meta-analyses;Systematic Reviews;2022-10-21

3. Quality of Evidence Supporting the Role of Tripterygium Glycosides for the Treatment of Diabetic Kidney Disease: An Overview of Systematic Reviews and Meta-Analyses;Drug Design, Development and Therapy;2022-05

4. Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: A systematic review and network meta-analysis;Pharmacological Research;2022-03